Cas no 10503-10-3 (4-Chloro-1H-indazole-3-carboxylic acid)
4-Chloro-1H-indazole-3-carboxylic acid Chemical and Physical Properties
Names and Identifiers
-
- 4-Chloro-1H-indazole-3-carboxylic acid
- 1H-Indazole-3-carboxylicacid, 4-chloro-
- 4-chloro-1H-indazol-3-carboxylic acid
- 4-CHLORO-3-INDAZOLE CARBOXYLIC ACID
- 1H-Indazole-3-carboxylicacid,4-chloro
- 4-CHLOROINDAZOLECARBOXYLIC ACID
- 4-Chloro-3-indazole carbocylic acid
- FT-0730109
- AS-40924
- AKOS006287012
- 10503-10-3
- 1h-indazole-3-carboxylicacid,4-chloro-
- AB31537
- A935558
- SCHEMBL7374273
- SY128274
- MFCD07367977
- CS-0309804
- AC-14391
- DTXSID20566734
- AMY31676
- EN300-1616849
- W-204543
- 4-Chloro-3-indazolecarboxylic acid
- 4-Chloro-1h-indazole-3-carboxylicacid
- DB-059288
-
- MDL: MFCD07367977
- Inchi: 1S/C8H5ClN2O2/c9-4-2-1-3-5-6(4)7(8(12)13)11-10-5/h1-3H,(H,10,11)(H,12,13)
- InChI Key: NKNNSGQMRFCVRC-UHFFFAOYSA-N
- SMILES: ClC1=CC=CC2=C1C(C(=O)O)=NN2
Computed Properties
- Exact Mass: 196.00400
- Monoisotopic Mass: 196.0039551g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 13
- Rotatable Bond Count: 1
- Complexity: 224
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2
- Topological Polar Surface Area: 66?2
Experimental Properties
- Density: 1.644
- Boiling Point: 472.1°Cat760mmHg
- Flash Point: 239.3°C
- Refractive Index: 1.744
- PSA: 65.98000
- LogP: 1.91450
4-Chloro-1H-indazole-3-carboxylic acid Customs Data
- HS CODE:2933990090
- Customs Data:
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
4-Chloro-1H-indazole-3-carboxylic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | C382880-10mg |
4-Chloro-1H-indazole-3-carboxylic Acid |
10503-10-3 | 10mg |
$ 184.00 | 2023-04-18 | ||
| TRC | C382880-50mg |
4-Chloro-1H-indazole-3-carboxylic Acid |
10503-10-3 | 50mg |
$ 839.00 | 2023-04-18 | ||
| TRC | C382880-100mg |
4-Chloro-1H-indazole-3-carboxylic Acid |
10503-10-3 | 100mg |
$ 1447.00 | 2023-04-18 | ||
| Alichem | A269001408-250mg |
4-Chloro-1H-indazole-3-carboxylic acid |
10503-10-3 | 95% | 250mg |
$231.12 | 2023-09-04 | |
| Alichem | A269001408-1g |
4-Chloro-1H-indazole-3-carboxylic acid |
10503-10-3 | 95% | 1g |
$566.04 | 2023-09-04 | |
| Alichem | A269001408-5g |
4-Chloro-1H-indazole-3-carboxylic acid |
10503-10-3 | 95% | 5g |
$1618.02 | 2023-09-04 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 45R0407-1g |
4-Chloro-1H-indazole-3-carboxylic acid |
10503-10-3 | 97% | 1g |
4223.25CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 45R0407-5g |
4-Chloro-1H-indazole-3-carboxylic acid |
10503-10-3 | 97% | 5g |
14840.74CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 45R0407-500mg |
4-Chloro-1H-indazole-3-carboxylic acid |
10503-10-3 | 97% | 500mg |
2535.65CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 45R0407-250mg |
4-Chloro-1H-indazole-3-carboxylic acid |
10503-10-3 | 97% | 250mg |
1687.6CNY | 2021-05-07 |
4-Chloro-1H-indazole-3-carboxylic acid Related Literature
-
Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
-
Doug Ogrin,Laura H. van Poppel,Simon G. Bott,Andrew R. Barron Dalton Trans., 2004, 3689-3694
-
Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
-
Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
Additional information on 4-Chloro-1H-indazole-3-carboxylic acid
Introduction to 4-Chloro-1H-indazole-3-carboxylic acid (CAS No. 10503-10-3)
4-Chloro-1H-indazole-3-carboxylic acid, identified by its Chemical Abstracts Service (CAS) number 10503-10-3, is a significant heterocyclic compound that has garnered considerable attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the indazole family, a class of nitrogen-containing heterocycles that are widely recognized for their diverse biological activities and structural versatility. The presence of both chloro and carboxylic acid functional groups in its molecular structure endows it with unique reactivity, making it a valuable intermediate in the synthesis of various pharmacologically active molecules.
The structural framework of 4-Chloro-1H-indazole-3-carboxylic acid consists of a fused bicyclic system comprising a benzene ring and a pyrrole ring, with a chlorine substituent at the 4-position and a carboxylic acid group at the 3-position. This specific arrangement of functional groups allows for facile modifications through various chemical transformations, such as nucleophilic substitution, esterification, and coupling reactions. These properties have made it a cornerstone in the development of novel therapeutic agents targeting a broad spectrum of diseases.
In recent years, 4-Chloro-1H-indazole-3-carboxylic acid has been extensively studied for its potential applications in drug discovery. Its indazole core is a privileged scaffold that has been incorporated into numerous lead compounds exhibiting antimicrobial, antiviral, anti-inflammatory, and anticancer activities. The chloro substituent at the 4-position serves as a reactive handle for further functionalization, enabling the construction of complex molecular architectures with tailored biological properties.
One of the most compelling aspects of 4-Chloro-1H-indazole-3-carboxylic acid is its role as a key intermediate in the synthesis of indazole-based drugs. For instance, researchers have utilized this compound to develop novel inhibitors of enzymes involved in cancer progression. The carboxylic acid group can be easily converted into esters or amides, which are common pharmacophores in drug design. Additionally, the chlorine atom can undergo cross-coupling reactions with boronic acids or halides, facilitating the introduction of diverse substituents into the indazole core.
Recent advancements in medicinal chemistry have highlighted the importance of 4-Chloro-1H-indazole-3-carboxylic acid in the development of targeted therapies. A notable example is its use in creating small-molecule inhibitors that selectively modulate kinases and other signaling proteins implicated in chronic diseases. The structural flexibility of this compound allows chemists to fine-tune its interactions with biological targets, enhancing both potency and selectivity. Such modifications are crucial for minimizing side effects and improving patient outcomes.
The pharmaceutical industry has also explored 4-Chloro-1H-indazole-3-carboxylic acid as a building block for antiviral agents. The indazole scaffold is known to exhibit broad-spectrum antiviral activity due to its ability to interfere with viral replication cycles. By incorporating this compound into drug candidates, scientists have been able to develop molecules that inhibit viral enzymes or disrupt viral assembly processes. These efforts have been particularly relevant in the context of emerging infectious diseases, where rapid development of effective treatments is essential.
Beyond its applications in human medicine, 4-Chloro-1H-indazole-3-carboxylic acid has found utility in agricultural chemistry. Researchers have harnessed its structural features to design novel pesticides and herbicides that target specific enzymatic pathways in pests while maintaining environmental safety. The ability to modify its functional groups allows for the creation of compounds with improved efficacy and reduced toxicity compared to traditional agrochemicals.
The synthesis of 4-Chloro-1H-indazole-3-carboxylic acid typically involves multi-step organic reactions starting from readily available precursors such as indole derivatives. Advanced synthetic methodologies, including palladium-catalyzed cross-coupling reactions and transition-metal-mediated transformations, have been employed to achieve high yields and purity levels. These synthetic strategies underscore the compound's importance as a versatile intermediate in industrial-scale chemical production.
In conclusion, 4-Chloro-1H-indazole-3-carboxylic acid (CAS No. 10503-10-3) is a multifaceted compound with significant implications in pharmaceutical research and industrial applications. Its unique structural features and reactivity make it an indispensable tool for chemists developing innovative therapeutic agents. As our understanding of biological systems continues to evolve, the demand for sophisticated heterocyclic compounds like this one is expected to grow, driving further advancements in drug discovery and material science.
10503-10-3 (4-Chloro-1H-indazole-3-carboxylic acid) Related Products
- 1079-46-5(Methyl 5-chloro-1H-indazole-3-carboxylate)
- 885519-31-3(6-Amino-4-chloro-3-indazolecarboxylic Acid)
- 129295-32-5(7-Chloro-1H-indazole-3-carboxylic acid)
- 885520-64-9(4,6-Dichloro-3-(1H)indazole Carboxylic Acid)
- 885278-48-8(Methyl 5,6-dichloro-1H-indazole-3-carboxylate)
- 1077-95-8(5-Chloro-1H-indazole-3-carboxylic Acid)
- 1072429-95-8(4,7-Dichloro-1H-indazole-3-carboxylic acid)
- 124459-91-2(5,6-Dichloro-1H-indazole-3-carboxylic Acid)
- 129295-31-4(6-Chloro-1H-indazole-3-carboxylic acid)
- 717134-47-9(Methyl 6-chloro-1H-indazole-3-carboxylate)